NASDAQ:SNSE

Sensei Biotherapeutics, Inc.

Stock

USD

Last Close

1.57

10/05 20:00

Market Cap

37.87M

Beta: −0.20

Volume Today

148.12K

Avg: 84.31K

PE Ratio

−0.55

PFCF: −0.57

Overview Financials Filings timeline people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
average inventory
average payables		2.28M -	3.67M 60.85%	3.17M 13.57%	1.23M 61.25%	2.24M 82.13%
average receivables
book value per share	-78.05 -	-5.57 92.86%	-1.91 65.75%	5.29 376.88%	3.37 36.30%	0.00 99.93%
capex per share	-0.05 -	-0.00 90.49%	-0.04 848.16%	-0.07 79.19%	-0.01 85.70%	-0.00 99.94%
capex to depreciation	-0.70 -	-0.73 3.05%	-5.77 694.78%	-2.96 48.74%	-0.24 91.94%	-0.13 44.09%
capex to operating cash flow	0.00 -	0.01 105.72%	0.07 1,001.56%	0.07 1.70%	0.01 87.72%	0.01 31.66%
capex to revenue
cash per share	0.95 -	0.02 97.86%	0.56 2,655.12%	5.33 848.80%	3.49 34.51%	0.00 99.93%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets	2.57 -	13.19 414.24%	0.03 99.80%	0.02 41.94%	0.07 341.71%	0.08 23.00%
debt to equity	-0.09 -	-0.23 163.49%	-0.01 95.70%	0.02 259.94%	0.08 383.50%	0.10 23.14%
dividend yield
earnings yield	-1.01 -	-0.08 91.90%	-0.04 54.75%	-0.23 531.25%	-1.07 357.69%	-0.00 99.83%
enterprise value	17.04M -	248.59M 1,358.62%	542.62M 118.28%	155.92M 71.27%	35.99M 76.92%	19.34B 53,633.74%
enterprise value over ebitda	-1.35 -	-20.11 1,394.61%	-30.19 50.13%	-4.33 85.65%	-0.72 83.45%	-521.71 72,660.33%
ev to operating cash flow	-1.65 -	-29.00 1,655.08%	-30.65 5.67%	-5.15 83.19%	-0.92 82.10%	-603.83 65,384.58%
ev to sales
free cash flow per share	-15.10 -	-0.70 95.36%	-0.64 8.63%	-1.17 82.10%	-1.28 10.00%	-0.00 99.91%
free cash flow yield	-0.80 -	-0.04 95.36%	-0.03 8.63%	-0.20 493.41%	-0.86 328.17%	-0.00 99.81%
graham net net	-79.80 -	-5.65 92.92%	-2.07 63.33%	5.09 345.29%	3.00 40.98%	0.00 99.93%
graham number	182.82 -	13.91 92.39%	5.48 60.63%	12.68 131.60%	10.98 13.46%	0.01 99.93%
income quality	0.79 -	0.51 35.27%	0.88 72.04%	0.82 6.64%	0.80 2.33%	0.94 16.91%
intangibles to total assets	0 -	0	0	0	0	0
interest coverage	-38.96 -	-5.51 85.85%	-11.52 108.93%	-55.94 385.78%	-229.17 309.65%	257.39 212.31%
interest debt per share	7.40 -	1.49 79.92%	0.08 94.87%	0.11 42.98%	0.27 146.29%	0.00 99.92%
inventory turnover
invested capital	-0.09 -	-0.23 163.49%	-0.01 95.70%	0.02 259.94%	0.08 383.50%	0.10 23.14%
market cap	12.95M -	232.78M 1,697.61%	558.65M 139.99%	160.72M 71.23%	45.75M 71.54%	19.34B 42,182.54%
net current asset value	-54.05M -	-69.38M 28.36%	-57.80M 16.69%	141.83M 345.40%	93.62M 33.99%	57.77M 38.29%
net debt to ebitda	-0.32 -	-1.28 295.65%	0.89 169.76%	0.13 85.03%	0.19 45.72%	0.18 5.64%
net income per share	-19.03 -	-1.54 91.90%	-0.70 54.75%	-1.35 93.72%	-1.59 17.58%	-0.00 99.92%
operating cash flow per share	-15.05 -	-0.70 95.38%	-0.60 13.93%	-1.09 82.30%	-1.27 16.40%	-0.00 99.91%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets	-7.05 -	-15.61 121.45%	-0.96 93.83%	-0.24 74.60%	-0.41 68.63%	-0.46 11.20%
revenue per share
roe	0.24 -	0.28 13.47%	0.37 32.11%	-0.26 169.96%	-0.47 84.58%	-0.53 11.33%
roic	0.27 -	0.27 0.30%	0.36 33.20%	-0.25 170.64%	-0.42 67.20%	-0.48 13.61%
sales general and administrative to revenue
shareholders equity per share	-78.05 -	-5.57 92.86%	-1.91 65.75%	5.29 376.88%	3.37 36.30%	0.00 99.93%
stock based compensation to revenue
tangible asset value	-53.48M -	-68.66M 28.39%	-56.44M 17.80%	146.51M 359.58%	103.41M 29.42%	64.89M 37.24%
tangible book value per share	-78.05 -	-5.57 92.86%	-1.91 65.75%	5.29 376.88%	3.37 36.30%	0.00 99.93%
working capital	-1.38M -	-21.21M 1,433.77%	15.25M 171.87%	143.65M 842.23%	99.52M 30.72%	61.61M 38.10%

All numbers in USD (except ratios and percentages)